INTEGRIS Cancer Institute of Oklahoma - Proton Campus

Oklahoma City, Oklahoma 73142

Use our guide to learn which trials are right for you!

We've found
2 trials
at this facility
Oncology Clinical Trial
CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
INTEGRIS Cancer Institute of Oklahoma - Proton Campus
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Connect® MDS/AML Disease Registry
Status: Enrolling, Phase
Updated: 12/31/1969
INTEGRIS Cancer Institute of Oklahoma - Proton Campus
mi
from
Oklahoma City, OK
Click here to add this to my saved trials